GEA Announces Figures for the Third Quarter

03.11.2016

GEA s order intake in the third quarter of 2016 was EUR 1,084 million.

The development was impacted by delays in the awarding of projects, above all in the dairy processing sector, a decline in orders from the oil and gas industry, and by the ongoing challenging economic environment in the dairy farming customer industry. Due to weaker growth in the Business Area Solutions, third-quarter revenue fell to EUR 1,101 million.

Operating EBITDA in the third quarter was EUR 113 million. The decline compared with the prior year s figure is largely explained by cost overruns in a few major projects and by the impact of reduced capacity utilization arising from the contraction in revenue.

"Although business remains solid in many of our customer industries, the group has experienced negative financial performance in certain areas during the third quarter, which cannot be fully compensated towards the end of the financial year. As a result, we have adjusted our forecast for the 2016 financial year a few days ago," said Jürg Oleas, Chairman of the Executive Board of GEA in his appraisal of the present situation.

More articles on this topic

ACHEMA 2024 Showcases Solutions for a More Sustainable and Resilient Process Industry

28.03.2024 -

In June, Frankfurt will once again be the centre of the chemical, pharmaceutical and biotechnology industries: The 34th ACHEMA will be opened by the German Federal Minister for Economic Affairs Robert Habeck on June 10. The ACHEMA kick-off will focus on the question of how the process industry can successfully position itself in a changing world. On all five days of the trade show, a diverse programme for young people will also contribute to securing the future of the industry.

Read more

Klaus Endress Celebrates His 75th Birthday

13.12.2023 -

Dr Klaus Endress, CEO of the Endress+Hauser Group for many years and president of the Supervisory Board since 2014, is celebrating his 75th birthday. As previously announced, he will end his active involvement in the family-owned business at the end of the year. However, he will remain closely associated with the Group as a shareholder and chairman of the Endress Family Council.

Read more

Peroxidic-Crosslinked Fluoroelastomer from Freudenberg Meets the Latest Regulatory Requirements of the Process Industry

26.04.2023 -

Freudenberg Sealing Technologies’ peroxidic-crosslinked fluoroelastomer material 75 FKM 239961 now also has received pharma-specific approval according to USP Chapter 87. The result of the in vitro conformity test confirms that the material has no toxic effects on cell cultures. With this advancement, bisphenol crosslinked FKM materials can be replaced in the food industry.

Read more